RELIEF THERAPEUTICS Holding SA (RLFTF)

0.09 0.00 (0.00%)
Delayed Data USD Disclaimer

RELIEF THERAPEUTICS Holding SA Company Profile

Industry
Biotechnology
Sector
Healthcare
Employees
10
Equity Type
ORD
Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need. The company focuses on clinical-stage programs based on molecules of natural origin (peptides and proteins) with a history of clinical use and either initial human activity with efficacy data or a strong scientific rationale. Its lead compound is RLF-100 (aviptadil), a synthetic human vasoactive intestinal peptide (VIP) with a multifaceted mode of action in respiratory indications is being investigated in two U.S. Phase 2b/3 clinical trials in acute respiratory deficiency due to COVID-19, as well as in Phase 2 clinical trial for the treatment of pulmonary sarcoidosis. The company is also involved in clinical development of RLF-100 for other indications in acute and chronic lung diseases. Relief Therapeutics Holding AG is based in Geneva, Switzerland.
Contact Information
Address
Geneva,1202 Switzerland
Phone
41 44 723 59 59
Fax
41 44 726 90 12
Top Executives
Name
Age
Since
Title
Raghuram Selvaraju 43 2016 Chairman of the Board
Paolo Galfetti 56 0000 President of Relief Europe & Director
Thomas Plitz 53 2020 Vice-Chairman
Patrice P. Jean 50 0000 Director
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.